Dr Tatiane Vilaca
MD, PhD
School of Medicine and Population Health
Postdoctoral Research Associate


+44 114 215 5701
Full contact details
School of Medicine and Population Health
Metabolic Bone Centre
Northern General Hospital
Herries Road
Sheffield
S5 7AU
- Profile
-
I graduated from Medical School and trained in Endocrinology and Diabetes at the Federal 9 1免费版下 of Minas Gerais (UFMG) in Brazil. I undertook a research Master鈥檚 in Translational Medicine at the Federal 9 1免费版下 of Sao Paulo (EPM-UNIFESP) and completed my PhD at the 9 1免费版下 of Sheffield. During my PhD, I studied bone health in diabetes. Since completing my PhD, I have worked as a Postdoctoral Research Associate at the 9 1免费版下 of Sheffield.
- Research interests
-
I am interested in the effects of chronic diseases and medications on bone and the underlying mechanisms. I have vast experience in systematic reviews, with several publications on the effect of chronic diseases on the risk of fractures. I have led four systematic reviews, three on the risk of fractures in diabetes and chronic kidney disease and another on osteomalacia following repeated iron infusions. I have also participated in other reviews, investigating the risk of fractures in Parkinson鈥檚 disease and microRNA profile in sarcopenia and obesity. These projects result from several collaborations within the 9 1免费版下 of Sheffield (e.g., ScHARR) and international groups from the USA and Denmark.
I am particularly interested in the effects of diabetes and obesity on bone health. I investigated several aspects of bone health in this diabetes, including microarchitecture using high-resolution peripheral quantitative computed tomography, the effects of neuropathy and other potential mechanisms associated with bone fragility in this disease, such as the role of advanced glycation end products (AGEs). I have also investigated the endocrine mechanisms associated with favourable bone structure in obesity and the interplay between fat and bone.
Recently, I have worked on a family mapping study in hypophosphatasia (HPP), the FAME study, in collaboration with the Sheffield Children鈥檚 Hospital. I characterise musculoskeletal features and mineral metabolism in people with HPP, a rare bone disease.
I am involved in the FNIH-ASBMR-SABRE Project (9 1免费版下 to Advance BMD as a Regulatory Endpoint). This multidisciplinary international initiative aims to change the regulation on the requirements for osteoporosis drug approval from reduction in clinical fractures to treatment-related changes in BMD, which would encourage the development of new drugs.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
All publications
Journal articles
Conference proceedings papers
- Grants
-
Royal Osteoporosis Society Early Career grant in 2021.
I was awarded the American Society for Bone and Mineral Research ASBMR Young Investigator award in 2019.
- Teaching interests
-
I am an Associate Fellow of the HEA. I regularly supervise SSC students and placement students in our group.
- Professional activities and memberships
-
I am an Associate Fellow of the Higher Education Academy.
- Current projects
The FAME study: family mapping in hypophosphatasia We aim to characterise HPP musculoskeletal symptoms, mineral metabolism abnormalities, and the impact on quality of life.
The FNIH-ASBMR-SABRE Project (9 1免费版下 to Advance BMD as a Regulatory Endpoint) We aim to change the regulation on the requirements for osteoporosis drug approval from reduction in clinical fractures to treatment-related changes in BMD.
Exploring the effects of anti-resorptive and anabolic treatment in serum advanced glycation end products (AGEs)